Dow Institute of Biological Biochemical & Pharmaceutical Sciences-IBBPS

𝐒𝐡𝐚𝐩𝐞 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬
𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐎𝐩𝐞𝐧 𝐍𝐨𝐰 | 𝐁𝐚𝐭𝐜𝐡 𝟎𝟑

Dow Institute of Biological, Biochemical & Pharmaceutical Sciences (IBBPS-DUHS) proudly announces 𝐏𝐚𝐤𝐢𝐬𝐭𝐚𝐧’𝐬 𝐟𝐢𝐫𝐬𝐭-𝐞𝐯𝐞𝐫 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐏𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥 𝐃𝐢𝐩𝐥𝐨𝐦𝐚 𝐏𝐫𝐨𝐠𝐫𝐚𝐦 – 𝐁𝐚𝐭𝐜𝐡 𝟎𝟑.

Advance your career in Pharmaceutical Regulatory Affairs through a comprehensive 6-month professional diploma program designed for pharmacists, healthcare professionals, industry experts, and aspiring regulatory professionals.

This program offers a unique blended learning opportunity with onsite and online classes and exclusive in-person interactive sessions in major cities of Pakistan.

📍 In-Person Sessions:
𝟐 𝐃𝐚𝐲𝐬 - 𝐋𝐚𝐡𝐨𝐫𝐞 | 𝟐 𝐃𝐚𝐲𝐬 - 𝐈𝐬𝐥𝐚𝐦𝐚𝐛𝐚𝐝

🔹 Mode: In-Person Classes
🔹 Online classes will continue to be available exclusively for participants residing outside Karachi.

Learn from distinguished national & international pharmaceutical experts:
🔹Mr. Sultan Ghani
🔹Dr. Syeda Rima Ishaq
🔹Dr. Izhar Hussain
🔹Dr.Shahnawaz Sajid PhD
🔹Mr. Hanif Ajari
🔹Mr. Anjum Shafi
🔹Mr. Barrister Rashid Mureed
🔹Mr. 𝐀𝐭𝐢𝐪 𝐮𝐫 𝐫𝐞𝐡𝐦𝐚𝐧
🔹Mr. Abdul Mughees Muddassir
🔹Ms. shabnam Perveen
🔹Mr. MUJAHID HUSSAIN
🔹Mr. Syed Imran
🔹Mr. 𝐌𝐮𝐡𝐚𝐦𝐦𝐚𝐝 𝐅𝐚𝐢𝐳𝐚𝐧

𝐆𝐚𝐢𝐧 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲-𝐟𝐨𝐜𝐮𝐬𝐞𝐝 𝐤𝐧𝐨𝐰𝐥𝐞𝐝𝐠𝐞 𝐢𝐧:

🔹 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐀𝐟𝐟𝐚𝐢𝐫𝐬
🔹 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭𝐬
🔹 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 & 𝐂𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞 𝐒𝐲𝐬𝐭𝐞𝐦𝐬
🔹 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧
🔹 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 & 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞𝐬

🔹 𝐋𝐚𝐬𝐭 𝐃𝐚𝐭𝐞 𝐨𝐟 𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧: 𝐀𝐮𝐠𝐮𝐬𝐭 𝟑𝟎, 𝟐𝟎𝟐𝟔
🔹 𝐂𝐥𝐚𝐬𝐬𝐞𝐬 𝐂𝐨𝐦𝐦𝐞𝐧𝐜𝐞: 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟎𝟓, 𝟐𝟎𝟐𝟔
🔹 𝐂𝐨𝐮𝐫𝐬𝐞 𝐅𝐞𝐞𝐬: 𝐏𝐊𝐑 𝟕𝟓,𝟎𝟎𝟎/-

🔹 Venue: Digital Library, "Gosha-e-Yousafi", Dow University of Health Sciences, Gulzar-e-Hijri, Karachi

Enhance your professional capabilities and take your regulatory career to the next level.

🔗 Register Now: https://lnkd.in/ePj7WGyK
📞 +92 326 800 9976


hashtag

🚨 𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞 𝐄𝐱𝐭𝐞𝐧𝐝𝐞𝐝!

Due to overwhelming interest and valuable participant feedback, registration for the Pharmaceutical Regulatory Sciences Professional Diploma – 𝐁𝐚𝐭𝐜𝐡 𝟎𝟑 has been extended!

This is your opportunity to gain practical, industry-focused knowledge through an in-person learning experience featuring meaningful interaction, collaborative learning, and direct knowledge-sharing with experienced pharmaceutical professionals.

📅 𝐋𝐚𝐬𝐭 𝐃𝐚𝐭𝐞 𝐭𝐨 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫: 𝟑𝟎 𝐀𝐮𝐠𝐮𝐬𝐭 𝟐𝟎𝟐𝟔
🎓 𝐂𝐥𝐚𝐬𝐬𝐞𝐬 𝐂𝐨𝐦𝐦𝐞𝐧𝐜𝐞: 𝟎𝟓 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟔

Secure your seat and take the next step toward advancing your career in Pharmaceutical Regulatory Sciences.

🔗 Register now: https://lnkd.in/ePj7WGyK

𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐁𝐢𝐨𝐞𝐪𝐮𝐢𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐚𝐬 𝐚 𝐆𝐚𝐭𝐞𝐰𝐚𝐲 𝐭𝐨 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭𝐬!

We are pleased to announce that Dr. Sm.Zeeshan, 𝐒𝐫. 𝐌𝐚𝐧𝐚𝐠𝐞𝐫 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 & 𝐁.𝐃, Dow Institute of Biological, Biochemical & Pharmaceutical Sciences (IBBPS-DUHS), Karachi, will be speaking at the 𝐏𝐡𝐚𝐫𝐦𝐚 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐒𝐮𝐦𝐦𝐢𝐭 𝟐𝟎𝟐𝟔.

𝐓𝐨𝐩𝐢𝐜: 𝐁𝐢𝐨𝐞𝐪𝐮𝐢𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐒𝐭𝐮𝐝𝐢𝐞𝐬 – 𝐀 𝐆𝐚𝐭𝐞𝐰𝐚𝐲 𝐭𝐨 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭𝐬

Bioequivalence studies play a critical role in demonstrating therapeutic equivalence and supporting the registration and international market access of pharmaceutical products. This session will explore how robust bioequivalence strategies can help the pharmaceutical industry navigate regulatory pathways and expand into global markets.

📅 𝟏𝟐–𝟏𝟑 𝐀𝐮𝐠𝐮𝐬𝐭 𝟐𝟎𝟐𝟔
📍 𝐓𝐮𝐥𝐢𝐩 𝐌𝐚𝐫𝐪𝐮𝐞𝐞, 𝐈𝐬𝐥𝐚𝐦𝐚𝐛𝐚𝐝, 𝐏𝐚𝐤𝐢𝐬𝐭𝐚𝐧

𝐔𝐩𝐜𝐨𝐦𝐢𝐧𝐠 𝐖𝐞𝐛𝐢𝐧𝐚𝐫: 𝐆𝐨𝐨𝐝 𝐒𝐭𝐨𝐫𝐚𝐠𝐞 𝐚𝐧𝐝 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐢𝐨𝐧 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞 𝐢𝐧 𝐒𝐮𝐩𝐩𝐥𝐲 𝐂𝐡𝐚𝐢𝐧 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲

Join us for an insightful expert-led webinar exploring the critical role of Good Storage and Distribution Practices in maintaining pharmaceutical quality and strengthening supply chain integrity. This session will highlight key practices, regulatory expectations, and strategies to ensure the quality, safety, and integrity of pharmaceutical products throughout the supply chain.

𝐃𝐚𝐭𝐞: 18 August 2026 (Tuesday)
𝐓𝐢𝐦𝐞: 11:00 AM – 12:00 PM (PKT)

𝐓𝐡𝐢𝐬 𝐖𝐞𝐛𝐢𝐧𝐚𝐫 𝐖𝐢𝐥𝐥 𝐂𝐨𝐯𝐞𝐫:
• Key principles of Good Storage and Distribution Practices
• Maintaining product quality and integrity across the supply chain
• Critical storage and transportation requirements
• Risk management and prevention of supply chain disruptions
• Regulatory expectations and compliance considerations
• Best practices for ensuring a secure and reliable pharmaceutical supply chain

𝐒𝐩𝐞𝐚𝐤𝐞𝐫: Waqas Ahmed Zaibi
International Regulatory Policy & Intelligence
US Pharmacopeia (USP Science & Research)

𝐌𝐨𝐝𝐞𝐫𝐚𝐭𝐨𝐫: Sahibzada Afridi
Business Development Officer

🔗 Register Now: https://lnkd.in/ddm6H9Fn

We're Exhibiting at Pak Pharma & Healthcare Expo 2026!

We are pleased to announce that the Dow Institute of Biological Biochemical & Pharmaceutical Sciences-IBBPS will be exhibiting at the Pak Pharma & Healthcare Expo 2026.

📅 12–13 August 2026
📍 Tulip Marquee, Islamabad, Pakistan
🏢 Hall #2 | Stall hashtag -18

Visit our team to explore our comprehensive research and laboratory services, including Bioequivalence (BE) Studies, Bioavailability (BA) Studies, Clinical Trials, Bioanalytical Testing, Quality Control Testing, Regulatory Support, and Clinical Research Training.

We look forward to connecting with pharmaceutical professionals, researchers, industry partners, and innovators to discuss opportunities for collaboration and advancing healthcare research in Pakistan.

See you at Hall #2, Stall hashtag -18!

Advancing clinical research through collaboration, innovation, and shared expertise.

Dow Institute of Biological Biochemical & Pharmaceutical Sciences-IBBPS was proud to participate in the 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 𝐒𝐮𝐦𝐦𝐢𝐭 𝐨𝐟 𝐏𝐚𝐤𝐢𝐬𝐭𝐚𝐧 (𝐂𝐓𝐒𝐏 𝟐𝟎𝟐𝟔), hosted by the National University of Medical Sciences | NUMS Official in Rawalpindi.
The summit brought together researchers, clinicians, regulators, academia, and industry leaders to discuss the future of clinical trials in Pakistan and strengthen the country's research ecosystem.

The event provided an excellent platform to exchange ideas, explore emerging trends, and foster meaningful collaborations that will contribute to ethical, innovative, and globally aligned clinical research.

At IBBPS–DUHS, we remain committed to supporting research excellence, regulatory compliance, and scientific innovation while working alongside national and international partners to advance healthcare through high-quality clinical research.

We extend our sincere appreciation to NUMS for organizing this impactful initiative and look forward to continued collaboration in strengthening Pakistan's clinical research landscape.

Proud to celebrate Salman Shad from Muller & Phipps Pakistan (Private) Limited. on completing Pakistan's First Professional Diploma in Pharmaceutical Regulatory Sciences!

A remarkable milestone that sets a new benchmark for regulatory excellence in Pakistan's pharmaceutical industry.

Dow Institute of Biological, Biochemical & Pharmaceutical Sciences (IBBPS-DUHS) Empowering Future Pharmaceutical Professionals.

Proud to celebrate Usama Ali from Bosch Pharmaceuticals (Pvt) Ltd.
on completing Pakistan's First Professional Diploma in Pharmaceutical Regulatory Sciences!

A remarkable milestone that sets a new benchmark for regulatory excellence in Pakistan's pharmaceutical industry.

Dow Institute of Biological, Biochemical & Pharmaceutical Sciences (IBBPS-DUHS) Empowering Future Pharmaceutical Professionals.

𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧𝐢𝐧𝐠 𝐏𝐡𝐚𝐬𝐞 𝐈𝐕 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 & 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐯𝐢𝐠𝐢𝐥𝐚𝐧𝐜𝐞 𝐢𝐧 𝐏𝐚𝐤𝐢𝐬𝐭𝐚𝐧 - 𝐒𝐞𝐦𝐢𝐧𝐚𝐫 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬

Thank you to everyone who joined us for an engaging and insightful seminar hosted by the Dow Institute of Biological Biochemical & Pharmaceutical Sciences-IBBPS .

We extend our sincere gratitude to METRICS RESEARCH (PRIVATE) LIMITED. Indus Hospital, Ziauddin University, Medisure Laboratories Pakistan (Pvt.) Ltd., Minerva Research Solutions, National University of Medical Sciences | NUMS Official, Aga Khan University for their valuable participation and for sharing their expertise and insights. Your contributions made this event a meaningful platform for advancing collaboration, clinical research, and pharmacovigilance in Pakistan.

Together, we continue building a stronger future for clinical research.

hashtag